Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.356
Buy
RSI(14)
48.867
Neutral
STOCH(KDJ)(9,3,3)
42.023
Sell
ATR(14)
1.935
High Vlolatility
CCI(14)
-23.065
Neutral
Williams %R
66.568
Sell
TRIX(12,20)
0.276
Sell
StochRSI(14)
0.000
Sell
Merit Medical Systems Inc
MMSI89.480USD
+0.690+0.78%
Market hours （ET）Quotes delayed by 15 min
5.30BMarket Cap
44.48P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-10Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
104.400
Target Price
+17.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 61.52.
Undervalued
The company’s latest PE is 43.78, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.62M shares, decreasing 1.15% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 6.82M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.08.
Financial Health
Currency: USD Updated：2025-09-10The company's current financial score is 7.69, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 355.35M, representing a year-over-year increase of 9.84%, while its net profit experienced a year-over-year increase of 6.75%.
Score
Financials
9.16
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.45
Operational Efficiency
7.51
Growth Potential
7.20
Shareholder Returns
7.10
Company Valuation
Currency: USD Updated：2025-09-10The company’s current valuation score is 4.80, which is higher than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 44.76, which is 13.31% below the recent high of 50.72 and 0.08% above the recent low of 44.73.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 5/208
No Data
Earnings Forecast
Currency: USD Updated：2025-09-10The company’s current earnings forecast score is 8.55, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Merit Medical Systems Inc is 103.00, with a high of 122.00 and a low of 90.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
11
analysts
Buy
Current Rating
104.400
Target Price
+17.58%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
118
Total
7
Median
8
Average
Company name
Ratings
Analysts
Merit Medical Systems Inc
MMSI
11
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-10The company’s current price momentum score is 9.51, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 94.07 and the support level at 84.27, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
91.580
Sell
MA10
91.005
Sell
MA20
89.045
Buy
MA50
88.149
Buy
MA100
91.369
Sell
MA200
96.617
Sell
Institutional Confidence
Currency: USD Updated：2025-09-10The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 110.80%, representing a quarter-over-quarter decrease of 1.77%. The largest institutional shareholder is The Vanguard, holding a total of 6.82M shares, representing 11.51% of shares outstanding, with 1.08% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Global Advisors (US)
Conestoga Capital Advisors, LLC
Fuller & Thaler Asset Management Inc.
Macquarie Investment Management
Fidelity Management & Research Company LLC
Geode Capital Management, L.L.C.
Two Sigma Investments, LP
1
2
Risk Assessment
Currency: USD Updated：2025-09-10The company's beta value is 0.64. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.60
VaR
+2.64%
240-Day Maximum Drawdown
+24.86%
240-Day Volatility
+30.28%
Return
Best Daily Return
60 days
+4.63%
120 days
+8.26%
5 years
+9.26%
Worst Daily Return
60 days
-10.31%
120 days
-11.02%
5 years
-11.37%
Sharpe Ratio
60 days
-0.26
120 days
-0.41
5 years
+0.51
Risk Assessment
Maximum Drawdown
240 days
+24.86%
3 years
+26.18%
5 years
+29.43%
Return-to-Drawdown Ratio
240 days
-0.34
3 years
+0.74
5 years
+0.45
Skewness
240 days
-1.19
3 years
-0.86
5 years
-0.32
Volatility
Realised Volatility
240 days
+30.28%
5 years
+31.44%
Standardised True Range
240 days
+2.59%
5 years
+2.12%
Downside Risk-Adjusted Return
120 days
-43.74%
240 days
-43.74%
Maximum Daily Upside Volatility
60 days
+16.53%
Maximum Daily Downside Volatility
60 days
+23.09%
Liquidity
Average Turnover Rate
60 days
+1.04%
120 days
+1.14%
5 years
--
Turnover Deviation
20 days
-8.30%
60 days
+19.45%
120 days
+30.22%
Peer Comparison
Currency: USD Updated：2025-09-10Merit Medical Systems Inc
MMSI
7.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
STVN
7.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Penumbra Inc
PEN
7.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
iRhythm Technologies Inc
IRTC
7.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Premier Inc
PINC
7.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
